CLDE225A2112

Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients


Fox Chase Cancer Center
333 Cottman Ave
Philadelphia, PA 19111
215-728-2674

Dana-Farber/Harvard Cancer Center
Boston, MA 02115
617-632-6066

Dartmouth Hitchcock Medical Center
One Medical Center Drive
Lebanon, NH 03756
603-650-9496

Medical University of South Carolina
171 Ashley Avenue
Charleston, SC 29425
843-792-4271

University of Kansas Cancer Center
3901 Rainbow Boulevard
Kansas City, KS 66160
913-588-6150

University of Texas Health Science Center at San Antonio
7703 Floyd Curl Drive
San Antonio, TX 78229
210-296-7335

University of Colorado Cancer Center - Anschutz Cancer Pavilion
1380 Lawrence Street
PO Box 173364 Campus Box 167
Aurora, CO 80045
720-848-0650

Huntsman Cancer Institute/University of Utah
2000 Circle of Hope
Salt Lake City, UT 84112
801-581-2955

City of Hope Comprehensive Cancer Center
1500 E Duarte Rd
Medical Office Bldg, 4th Floor
Duarte, CA 91010
800-826-4673